Kızamık ve Subakut Sklerozan Panensefalit: Oluşum ve Patogenezi

Anlar B, Yalaz K. Measles virus infection and subacute sclerosing panencephalitis. Jackson AC (ed.) Viral infections of the human nervous system içinde. Berlin: Springer; 2013. p.3-22.

Watanabe S, Shirogane Y, Sato Y, et al. New Insights into Measles Virus Brain Infections. Trends Microbiol. 2019;27(2):164-75.doi: 10.1016/j.tim.2018.08.010

Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J. 2002;78(916):63-70.doi: 10.1136/pmj.78.916.63

Miller C, Farrington CP, Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol. 1992;21(5):998-1006. doi: 10.1093/ije/21.5.998

Garg RK. Subacute sclerosing panencephalitis. J Neurol. 2008;255(12):1861-71. doi: 10.1007/s00415-008-0032-6

Öztürk A, Gürses C, Baykan, et al. Subacute sclerosing panencephalitis: clinical and magnetic resonance imaging evaluation of 36 patients. J Child Neurol. 2002;17(1):25-9.doi: 10.1177/088307380201700106

Bellini WJ, Rota JS, Lowe LE, et al. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis. 2005;192(10):1686-93.doi: 10.1086/497169

Praveen-kumar S, Sinha S, Taly AB, et al. Electroencephalographic and imaging profile in a subacute sclerosing panencephalitis (SSPE) cohort: a correlative study. Clin Neurophysiol. 2007;118(9):1947-54. doi: 10.1016/j.clinph.2007.06.008

Yilmaz D, Aydin OF, Senbil N, et al. Subacute sclerosing panencephalitis: is there something different in the younger children? Brain Dev. 2006;28(10):649-52. doi: 10.1016/j.braindev.2006.04.008

Yildirim M, Ayvaz DC, Konuskan B, et al. Neurologic Involvement in Primary Immunodeficiency Disorders. J Child Neurol. 2018;33(5):320-8. doi: 10.1177/0883073817754176

Onal AE, Gurses C, Direskeneli GS, et al. Subacute sclerosing panencephalitis surveillance study in Istanbul. Brain Dev. 2006;28(3):183-9. doi: 10.1016/j.braindev.2005.07.004

Leung AK, Hon KL, Leong KF, et al. Measles: a disease often forgotten but not gone. Hong Kong Med J. 2018;24(5):512-20. doi: 10.12809/hkmj187470

Griffin DE. Measles Virus. Knipe D (ed.) Fields Virology içinde. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 2013. p.1151-1586.

Laksono BM, de Vries RD, McQuaid S, et al. Measles Virus Host Invasion and Pathogenesis. Viruses. 2016;8(8). doi: 10.3390/v8080210

Plattet P, Alves L, Herren M, et al. Measles Virus Fusion Protein: Structure, Function and Inhibition. Viruses. 2016;8(4):112. doi: 10.3390/v8040112

Lawrence DM, Patterson CE, Gales TL, et al. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J Virol. 2000;74(4):1908-18. doi: 10.1128/jvi.74.4.1908-1918.2000

Otaki M, Sada K, Kadoya H, et al. Inhibition of measles virus and subacute sclerosing panencephalitis virus by RNA interference. Antiviral Res. 2006;70(3):105-11. doi: 10.1016/j.antiviral.2006.01.009

Rima BK, Duprex WP. Molecular mechanisms of measles virus persistence. Virus Res. 2005;111(2):132-47. doi: 10.1016/j.virusres.2005.04.005

Anlar B. Subacute sclerosing panencephalitis and chronic viral encephalitis. Handb of clinical neurology. 2013;112:1183-9. doi: 10.1016/B978-0-444-52910-7.00039-8

Villar J, Salazar ML, Jiménez JM, et al. C-type lectin receptors MR and DC-SIGN are involved in recognition of hemocyanins, shaping their immunostimulatory effects on human dendritic cells. Eur J Immunol. 2021;51(7):1715-31.doi: 10.1002/eji.202149225

Bottermann M, James LC. Intracellular Antiviral Immunity. Adv Virus Res. 2018;100:309-54. doi: 10.1016/bs.aivir.2018.01.002

López de Padilla CM, Niewold TB. The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases. Gene. 2016;576(1 Pt 1):14-21. doi: 10.1016/j.gene.2015.09.058

Wicherska-Pawłowska K, Wróbel T, Rybka J. Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases. Int J Mol Sci. 2021;22(24). doi: 10.3390/ijms222413397

Bieback K, Lien E, Klagge IM, et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol. 2002;76(17):8729-36. doi: 10.1128/jvi.76.17.8729-8736.2002. doi: 10.1128/JVI.76.17.8729-8736.2002

Strauss-Albee DM, Blish CA. Human NK Cell Diversity in Viral Infection: Ramifications of Ramification. Front Immunol. 2016;7:66. doi: 10.3389/fimmu.2016.00066

Kak G, Raza M, Tiwari BK. Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases. Biomol Concepts. 2018;9(1):64-79. doi: 10.1515/bmc-2018-0007.

Kaech SM, Cui W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol. 2012;12(11):749-61. doi: 10.1038/nri3307

Zhang N, Bevan MJ. CD8(+) T cells: foot soldiers of the immune system. Immunity. 2011;35(2):161-8. doi: 10.1016/j.immuni.2011.07.010

Lettau M, Kabelitz D, Janssen O. Lysosome-Related Effector Vesicles in T Lymphocytes and NK Cells. Scand J Immunol. 2015;82(3):235-Oldstone MB. Modeling subacute sclerosing panencephalitis in a transgenic mouse system: uncoding pathogenesis of disease and illuminating components of immune control. Curr Top Microbiol Immunol. 2009;330:31-54. doi: 10.1007/978-3-540-70617-5_2

Yentür SP, Demirbilek V, Gurses C, et al. Immune alterations in subacute sclerosing panencephalitis reflect an incompetent response to eliminate the measles virus. PLoS One. 2021;16(1):e0245077. doi: 10.1371/journal.pone.0245077

Hara T, Yamashita S, Aiba H, et al. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol. 2000;6(2):121-6. doi: 10.3109/13550280009013155

Aydin OF, Ichiyama T, Anlar B. Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis. Brain Dev. 2010;32(6):463-6. doi: 10.1016/j.braindev.2009.04.018

Ichiyama T, Siba P, Suarkia D, et al. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea. Cytokine. 2006;33(1):17-20. doi: 10.1016/j.cyto.2005.11.009

Mistchenko AS, Fornari MC, Viegas M, et al. Detection of interleukin 10 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis. J Neurovirol. 2005;11(1):66-9. doi: 10.1080/13550280590901769

Shuttleworth S, Townsend P, Silva F, et al. Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases. Prog Med Chem. 2011;50:109-33. doi: 10.1016/B978-0-12-381290-2.00003-3

Kusuhara K, Sasaki Y, Nakao F, et al. Analysis of measles virus binding sites of the CD46 gene in patients with subacute sclerosing panencephalitis. J Infect Dis. 2000;181(4):1447-9. doi: 10.1086/315386

Inoue T, Kira R, Nakao F, et al. Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol. 2002;59(5):822-7. doi: 10.1001/archneur.59.5.822

Torisu H, Kusuhara K, Kira R, et al. Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology. 2004;62(3):457-60. doi: 10.1212/01.wnl.0000106940.95749.8e

Pipo-Deveza JR, Kusuhara K, Silao CL, et al. Analysis of MxA, IL-4, and IRF-1 genes in Filipino patients with subacute sclerosing panencephalitis. Neuropediatrics. 2006;37(4):222-8. doi: 10.1055/s-2006-924724

Yilmaz V, Demirbilek V, Gürses C, et al. Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol. 2007;13(5):410-5. doi: 10.1080/13550280701455383

Ishizaki Y, Takemoto M, Kira R, et al. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. J Neurovirol. 2008;14(6):486-91. doi: 10.1080/13550280802298120

Piskin IE, Karakas-Celik S, Calik M, et al. Association of interleukin 18, interleukin 2, and tumor necrosis factor polymorphisms with subacute sclerosing panencephalitis. DNA Cell Biol. 2013;32(6):336-40. doi: 10.1089/dna.2013.1997

Piskin IE, Calık M, Abuhandan M, et al. PD-1 gene polymorphism in children with subacute sclerosing panencephalitis. Neuropediatrics. 2013;44(4):187-90. doi: 10.1055/s-0033-1338134

Karakas-Celik S, Piskin IE, Keni MF, et al. May TLR4 Asp299Gly and IL17 His161Arg polymorphism be associated with progression of primary measles infection to subacute sclerosing panencephalitis?. Gene. 2014;547(2):186-90. doi: 10.1016/j.gene.2014.03.056

Yentur SP, Aydin HN, Gurses C, et al. Granzyme B gene polymorphism associated with subacute sclerosing panencephalitis. Neuropediatrics. 2014;45(5):309-13. doi: 10.1055/s-0034-1378129

Dundar NO, Gencpinar P, Sallakci N, et al. Interleukin-12 (-1188) A/C and interferon-γ (+874) A/T gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol. 2016;22(5):661-5. doi: 10.1007/s13365-016-0442-7

Cakmak-Genc G, Dursun A, Karakas Celik S, et al. IL28B, IL29 and micro-RNA 548 in subacute sclerosing panencephalitis as a rare disease. Gene. 2018;678:73-8. doi: 10.1016/j.gene.2018.07.062